EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations

George Kroumpouzos iD, Patrick Treacy iD

JMIR Dermatology · 2024-01-17 · 7 · e50403

DOI: 10.2196/50403 ↗

At a glance

Übersichtsarbeit in JMIR Dermatology, published online on 2024-01-17. Written by George Kroumpouzos and 1 co-authors. Institution: GK Dermatology, PC, South Weymouth, MA, United States. Cited 92 times so far (Crossref); 79 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Hyaluronidase (Hyal) can reverse complications of hyaluronic acid (HA) fillers, which has contributed substantially to the popularity of such procedures. Still, there are differing opinions regarding Hyal treatment, including dosage recommendations in filler complication management.

Objective

We aimed to address unanswered questions regarding Hyal treatment for HA filler complications, including timing and dosage, skin pretesting, properties of various Hyals and interactions with HA gels, and pitfalls of the treatment.

Methods

PubMed and Google Scholar databases were searched from inception for articles on Hyal therapy for filler complications. Articles were evaluated regarding their contribution to the field. The extensive literature review includes international leaders’ suggestions and expert panels’ recommendations.

Results

There are limited controlled data but increasing clinical experience with Hyal treatment. The currently used Hyals provide good results and have an acceptable safety profile. Nonemergent complications such as the Tyndall effect, noninflamed nodules, and allergic or hypersensitivity reactions should be treated with low or moderate Hyal doses. Hyal should be considered with prior or simultaneous oral antibiotic treatment in managing inflammatory nodules. Hyal may be tried for granulomas that have not responded to intralesional steroids. Emergent complications such as vascular occlusion and blindness require immediate, high-dose Hyal treatment. Regarding blindness, the injection technique, retrobulbar versus supraorbital, remains controversial. Ultrasound guidance can increase the efficacy of the above interventions.

Conclusions

Hyal is essential in aesthetic practice because it can safely treat most HA filler complications. Immediate Hyal treatment is required for emergent complications. Aesthetic practitioners should be versed in using Hyal and effective dosage protocols.

Subjects

Author keywords

applicationcomplicationsdatadosagefillerhyaluronic acidhyaluronidaseinflammatoryinflammatory noduleinjectionmanagementnoduleskintherapytreatment

Authors and institutions

  • GK Dermatology, PC, South Weymouth, MA, United States.
  • Department of Dermatology, Warren Alpert Medical School at Brown University, Providence, RI, United States.
  • Ailesbury Clinics Ltd, Dublin, Ireland.

ORCID profiles: George Kroumpouzos, Patrick Treacy

Cite

APA

Kroumpouzos, G., & Treacy, P. (2024). Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. JMIR Dermatology, 7, e50403. https://doi.org/10.2196/50403

Vancouver

Kroumpouzos G, Treacy P. Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations. JMIR Dermatology. 2024;7:e50403. doi:10.2196/50403

BibTeX
@article{Kroumpouzos2024,
  author = {Kroumpouzos, George and Treacy, Patrick},
  title = {Hyaluronidase for Dermal Filler Complications: Review of Applications and Dosage Recommendations},
  journal = {JMIR Dermatology},
  year = {2024},
  volume = {7},
  pages = {e50403},
  doi = {10.2196/50403}
}
Start for free →